RCAN2
Calcipressin-2
Also known as: DSCR1L1, RCAN2_HUMAN, ZAKI-4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14206
- Gene
- RCAN2
- Ensembl
- ENSG00000172348
- Chromosome
- 6
- Canonical length
- 197 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Microtubules,Primary cilium,Mitochondria
OverviewNCBI Gene
This gene encodes a member of the regulator of calcineurin (RCAN) protein family. These proteins play a role in many physiological processes by binding to the catalytic domain of calcineurin A, inhibiting calcineurin-mediated nuclear translocation of the transcription factor NFATC1. Expression of this gene in skin fibroblasts is upregulated by thyroid hormone, and the encoded protein may also play a role in endothelial cell function and angiogenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
197 residues, UniProt reviewed canonical sequence.
>Q14206|RCAN2
1 MPAPSMDCDV STLVACVVDV EVFTNQEVKE KFEGLFRTYD DCVTFQLFKS FRRVRINFSN
61 PKSAARARIE LHETQFRGKK LKLYFAQVQT PETDGDKLHL APPQPAKQFL ISPPSSPPVG
121 WQPINDATPV LNYDLLYAVA KLGPGEKYEL HAGTESTPSV VVHVCDSDIE EEEDPKTSPK
181 PKIIQTRRPG LPPSVSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCAN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 194 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 194 nTPM
- heart muscle: 187 nTPM
- tongue: 168 nTPM
- cerebral cortex: 102 nTPM
- midbrain: 85 nTPM
- parathyroid gland: 80 nTPM
Single-cell type
- cardiomyocytes: 1,680 nCPM
- renal collecting duct intercalated cells: 1,641 nCPM
- myonuclei: 1,222 nCPM
- vascular smooth muscle cells: 1,220 nCPM
- salivary ionocytes: 883 nCPM
- thymic myoid cells: 559 nCPM
Immune cell
- memory CD8 T-cell: 2.1 nTPM
- gdT-cell: 1.7 nTPM
- naive CD8 T-cell: 1.5 nTPM
- memory CD4 T-cell: 1.1 nTPM
- total PBMC: 0.4 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 243 nTPM
- midbrain: 187 nTPM
- pons: 169 nTPM
- thalamus: 163 nTPM
- hypothalamus: 161 nTPM
- white matter: 151 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.83
- gnomAD missense Z
- 1.18
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcineurin-NFAT signaling cascade
- calcium-mediated signaling
- locomotion involved in locomotory behavior
- Notch signaling pathway
- response to oxidative stress
- short-term memory
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Calcipressin
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- Calcipressin
- Calcipressin-2, RNA recognition motif
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCAN2 as an antibody target. Whether an autoantibody or antibody against RCAN2 could matter depends on whether native RCAN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCAN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCAN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...